BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251021
DTEND;VALUE=DATE:20251022
DTSTAMP:20260413T072853
CREATED:20251007T173951Z
LAST-MODIFIED:20251007T173951Z
UID:6322-1761004800-1761091199@www.immunologypodcast.com
SUMMARY:Dr. Matteo Iannacone
DESCRIPTION:Dr. Matteo Iannacone is a Professor and Group Leader at the San Raffaele Scientific Institute. The Iannacone lab’s work centers on understanding how immune responses are orchestrated within local tissue niches. Their goal is to uncover novel principles of tissue immunity and leverage them for more precise immunotherapeutic strategies.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-matteo-iannacone
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/10/Matteo-Iannacone-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251008
DTSTAMP:20260413T072853
CREATED:20250826T211022Z
LAST-MODIFIED:20250826T211022Z
UID:6284-1759795200-1759881599@www.immunologypodcast.com
SUMMARY:Dr. Robin Orozco
DESCRIPTION:Dr. Robin Orozco is an Assistant Professor at the University of Kansas. Her lab uses a variety of transgenic murine models to dissect the molecular and cellular mechanisms a particular mutation is impacting viral replication\, immune cell function\, and viral associated pathologies. Currently\, they study the contribution of the common pro-autoimmune allele of PTPN22 (rs2476601) in regulating the balance between protection and pathology during virus infection.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-robin-orozco
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/08/Robin-Orozco-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250821T160000
DTEND;TZID=America/New_York:20250821T170000
DTSTAMP:20260413T072853
CREATED:20250702T180430Z
LAST-MODIFIED:20250702T180430Z
UID:6212-1755792000-1755795600@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: The Evolution of mRNA-Based Dendritic Cell Cancer Vaccines
DESCRIPTION:Join us live from the IUIS 2025 Congress in Vienna for a special episode of the Immunology Podcast featuring Dr. Zwi Berneman\, a leader in cancer immunotherapy. In this special recording\, hosts Drs. Brenda Raud and Jason Goldsmith will guide Dr. Berneman through the two-decade evolution of mRNA-based dendritic cell vaccination\, highlighting its applications in both hematologic malignancies like acute myeloid leukemia and solid tumors such as mesothelioma and glioblastoma. Together\, they will explore the journey of scientific discovery\, clinical breakthroughs\, and real-world impact\, as Dr. Berneman reflects on the lessons learned and what the future holds for personalized immunotherapy. \nDate: Thursday\, August 21\, 2025\nTime: 4:00 – 5:00 p.m.\nLocation: Austria Center Vienna\, Hall M
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-the-evolution-of-mrna-based-dendritic-cell-cancer-vaccines
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/07/Photo_Zwi-BERNEMAN-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250729
DTEND;VALUE=DATE:20250730
DTSTAMP:20260413T072853
CREATED:20250521T180723Z
LAST-MODIFIED:20250521T180723Z
UID:6172-1753747200-1753833599@www.immunologypodcast.com
SUMMARY:Dr. Tamara Tilburgs
DESCRIPTION:Dr. Tamara Tilburgs is an Assistant Professor in the UC Department of Pediatrics at Cincinnati Children’s Hospital. The Tilburgs lab investigates how maternal immune cells establish immune tolerance to fetal and placental allo-antigens and remain competent to respond to infections both systemically and in placental tissues. Their current projects are transforming the understanding of how interactions between fetal trophoblasts and maternal immune cells establish maternal fetal tolerance and immunity to infection as well as how defects in these processes may contribute to the development of pregnancy complications.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-tamara-tilburgs
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/05/Tamara-Tilburgs-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250701
DTEND;VALUE=DATE:20250702
DTSTAMP:20260413T072853
CREATED:20250627T205559Z
LAST-MODIFIED:20250627T205559Z
UID:6201-1751328000-1751414399@www.immunologypodcast.com
SUMMARY:Dr. Mahima Swamy
DESCRIPTION:Dr. Mahima Swamy is a Programme Leader at the University of Dundee. Her main research interest is to understand how intestinal intraepithelial lymphocytes coordinate immune responses to chemical\, dietary and microbial inputs at the intestinal epithelium. They are exploring how immune homeostasis is maintained at the barrier\, and how dysregulated intraepithelial lymphocytes can be controlled.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mahima-swamy
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/06/Mahima-Swamy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250603
DTEND;VALUE=DATE:20250604
DTSTAMP:20260413T072853
CREATED:20250602T172329Z
LAST-MODIFIED:20250603T163600Z
UID:6181-1748908800-1748995199@www.immunologypodcast.com
SUMMARY:Dr. Arthur Mortha
DESCRIPTION:Dr. Arthur Mortha is an Associate Professor at the University of Toronto. His lab investigates the biology of innate lymphoid cells\, focusing on their roles in tissue immunity\, regeneration\, and interactions with non-hematopoietic cells at mucosal sites. They also explore how mononuclear phagocytes mediate immune responses to commensal microbiota.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-arthur-mortha
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/06/Arthur-Mortha-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250505T100000
DTEND;TZID=America/New_York:20250505T111500
DTSTAMP:20260413T072853
CREATED:20250314T225300Z
LAST-MODIFIED:20250501T150545Z
UID:6066-1746439200-1746443700@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: Insights from 100 Conversations with Immunologists
DESCRIPTION:Join the Immunology Podcast for a live show at IMMUNOLOGY2025™\, as Brenda and Jason reflect on trends and perspectives in immunology\, drawing from four years of candid conversations with researchers in the field. Don’t miss this opportunity to hear behind-the-scenes stories\, ask your own questions\, and gain fresh perspectives on the future of immunology. \nDate: Monday\, May 5\, 2025\nTime: 10:00 – 11:15 a.m.\nLocation: Hawai’i Convention Center\, Room 319AB
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-insights-from-100-conversations-with-immunologists
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/05/Jason-and-Brenda-square.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250422
DTEND;VALUE=DATE:20250423
DTSTAMP:20260413T072853
CREATED:20250407T192512Z
LAST-MODIFIED:20250407T192512Z
UID:6093-1745280000-1745366399@www.immunologypodcast.com
SUMMARY:Dr. Henrique Veiga-Fernandes
DESCRIPTION:Dr. Henrique Veiga-Fernandes is a Full Investigator and Group Leader at the Champalimaud Foundation. \nThe Veiga-Fernandes lab studies the role of cross-talk between neurons and the immune system in the prevention and resolution of disease. They mainly focus on mucosal barriers\, such as the intestine and the lung. These organs are in permanent contact with the external environment and have a complex and dense network of neuronal and immune cells. This combination of features makes these organs an optimal site to reveal how the neural and immune systems work together to preserve health. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-henrique-veiga-fernandes
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/04/henrique-veiga-fernandes-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250408
DTEND;VALUE=DATE:20250409
DTSTAMP:20260413T072853
CREATED:20250307T193650Z
LAST-MODIFIED:20250407T184748Z
UID:6089-1744070400-1744156799@www.immunologypodcast.com
SUMMARY:Dr. Monika Wolkers
DESCRIPTION:Dr. Monika Wolkers is a Research Group Head at the Sanquin Blood Supply Foundation and an Associate Professor at the University of Amsterdam. Dr. Wolkers’ lab investigates molecular mechanisms that define the levels of cytokine production in effector T cells and in exhausted T cells\, with a focus on post-transcriptional regulation. They aim to manipulate these mechanisms to reprogram exhausted tumor-infiltrating T cells back into proficient effector T cells.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-monika-wolkers
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/04/Monika-Wolkers-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250311
DTEND;VALUE=DATE:20250312
DTSTAMP:20260413T072853
CREATED:20241217T184155Z
LAST-MODIFIED:20241217T184155Z
UID:5984-1741651200-1741737599@www.immunologypodcast.com
SUMMARY:Dr. Peter Doherty
DESCRIPTION:Dr. Peter Doherty shared the Nobel Prize in Physiology or Medicine in 1996 with Swiss colleague Rolf Zinkernagel\, for their discovery of how the immune system recognizes virus-infected cells. He was Australian of the Year in 1997\, and has since been commuting between St Jude Children’s Research Hospital in Memphis and the Department of Microbiology and Immunology at the University of Melbourne. His research is mainly in the area of defense against viruses. He regularly devotes time to delivering public lectures\, writing articles for newspapers and magazines and participating in radio discussions. \nPeter Doherty graduated from the University of Queensland in Veterinary Science and became a veterinary officer. Moving to Scotland\, he received his PhD from the University of Edinburgh Medical School. He is the first person with a veterinary qualification to win a Nobel Prize. \nPeter is also the author of several books\, including “The Beginners Guide to Winning the Nobel Prize”\, “A Light History of Hot Air”\, “Sentinel Chickens: What birds tell us about our health and the world”\, “Pandemics: What Everyone Needs to Know”\, “The Knowledge Wars” and “The incidental Tourist”.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-peter-doherty
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/12/Peter-Doherty-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250225
DTEND;VALUE=DATE:20250226
DTSTAMP:20260413T072853
CREATED:20250206T234436Z
LAST-MODIFIED:20250225T214930Z
UID:6023-1740441600-1740527999@www.immunologypodcast.com
SUMMARY:Dr. Luke O'Neill
DESCRIPTION:Dr. Luke O’Neill is a Professor and Chair of Biochemistry at Trinity College Dublin. His research group is focused on the molecular basis of inflammation\, with a particular emphasis on innate immunity and immunometabolism. They and other groups have shown that several metabolites\, such as succinate\, itaconate\, and fumarate\, and enzymes\, such as PKM2 and GAPDH play specific roles in the immune response in macrophages. They endeavor to provide a better understanding into the metabolic regulation of immune cell function and the innate immune system\, with the aim of developing novel therapies to treat inflammatory diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-luke-oneill
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/02/Luke-ONeill-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250129
DTSTAMP:20260413T072853
CREATED:20240903T233235Z
LAST-MODIFIED:20250122T202050Z
UID:5883-1738022400-1738108799@www.immunologypodcast.com
SUMMARY:Dr. Erica Saphire
DESCRIPTION:Dr. Erica Saphire is a Professor\, President & Chief Executive Officer at La Jolla Institute for Immunology. Her research explains\, at the molecular level\, how and why viruses are pathogenic and provides the roadmap for medical defense. Her team has solved the structures of the Ebola\, Sudan\, Marburg\, Bundibugyo and Lassa virus glycoproteins\, explained how they remodel these structures as they drive themselves into cells\, how their proteins suppress immune function and where human antibodies can defeat these viruses.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-erica-saphire
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/09/Erica-Saphire-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241203
DTEND;VALUE=DATE:20241204
DTSTAMP:20260413T072853
CREATED:20241127T193039Z
LAST-MODIFIED:20241216T231955Z
UID:5970-1733184000-1733270399@www.immunologypodcast.com
SUMMARY:Dr. Lili Yang
DESCRIPTION:Dr. Lili Yang is a Professor of Microbiology\, Immunology\, and Molecular Genetics at the University of California\, Los Angeles. Her research centers on deciphering the molecular mechanisms regulating anti-cancer immune responses\, exploiting knowledge to develop novel immunotherapies for treating cancer\, and translating these new cancer immunotherapies from bench to bedside. Their research also extends to studying immune regulation of other chronic diseases including infections\, allergies\, and autoimmune diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-lili-yang
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/11/zLiliYang-Portrait-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241120
DTSTAMP:20260413T072853
CREATED:20241104T075642Z
LAST-MODIFIED:20241104T075642Z
UID:5952-1731974400-1732060799@www.immunologypodcast.com
SUMMARY:Dr. Rahul Roychoudhuri
DESCRIPTION:Dr. Rahul Roychoudhuri is a Professor of Professor of Cancer Immunology at the University of Cambridge. His research aims to uncover the molecular and cellular mechanisms underpinning immune regulation and cancer immunosuppression. They study how T cell immunity is suppressed in cancer and Treg development and function.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-rahul-roychoudhuri
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/11/Rahul-Roychoudhuri-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241105
DTEND;VALUE=DATE:20241106
DTSTAMP:20260413T072853
CREATED:20241024T184722Z
LAST-MODIFIED:20241118T181323Z
UID:5935-1730764800-1730851199@www.immunologypodcast.com
SUMMARY:Dr. Pascal Meier
DESCRIPTION:Dr. Pascal Meier is a Professor and Group Leader at the Institute of Cancer Research. His group investigates the complex relationship between cell death\, immunity and tumorigenesis. Particularly\, they focus on the role of cell death and inflammation in adaptation to tissue stress\, treatment resistance\, and tumor surveillance. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-pascal-meier
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/10/Pascal-Meier-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241022
DTEND;VALUE=DATE:20241023
DTSTAMP:20260413T072853
CREATED:20241021T005347Z
LAST-MODIFIED:20241021T005347Z
UID:5926-1729555200-1729641599@www.immunologypodcast.com
SUMMARY:Drs. Joanne Flynn and Stephen Hedrick
DESCRIPTION:Dr. JoAnne Flynn is a Professor of Microbiology & Molecular Genetics at the University of Pittsburgh. Dr. Flynn’s career has been largely focused on the immunology of tuberculosis (TB). She identified several immune factors that were involved in controlling TB and was the President of the American Association of Immunologists (AAI) from 2018-2019. \nDr. Stephen Hedrick is Chancellor’s Associates Chair VII and Distinguished Professor Emeritus at the University of California San Diego.  Dr. Hedrick is a Distinguished Fellow of AAI and was the recipient of the AAI Distinguished Service Award in 1997. He has a strong track record of eloquently advocating for childhood vaccination.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-joanne-flynn-and-stephen-hedrick
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/10/JoAnne-and-Stephen-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241008
DTEND;VALUE=DATE:20241009
DTSTAMP:20260413T072853
CREATED:20240905T185823Z
LAST-MODIFIED:20241018T181113Z
UID:5886-1728345600-1728431999@www.immunologypodcast.com
SUMMARY:Dr. Theresa Alenghat
DESCRIPTION:Dr. Theresa Alenghat is a Professor in the Immunobiology Division and Margaret K. Hostetter Chair at Cincinnati Children’s Hospital Medical Center\, University of Cincinnati. Her lab investigates mechanisms underlying the host-microbiota relationship\, and how this regulation affects intestinal immunity and inflammatory bowel disease. Dr. Alenghat has led studies revealing that epigenetics and histone deacetylases permit intestinal epithelial cells to sense commensal bacteria and convey this information to the mammalian host. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-theresa-alenghat
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/Theresa-Alenghat-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240925
DTSTAMP:20260413T072853
CREATED:20240821T230644Z
LAST-MODIFIED:20241008T204514Z
UID:5863-1727136000-1727222399@www.immunologypodcast.com
SUMMARY:Dr. Roslyn Kemp
DESCRIPTION:Dr. Roslyn Kemp is a Professor of Immunology at the University of Otago. Dr. Kemp’s research focuses on T cells as mediators of anti-tumour immunity and inflammation. Specifically\, they study the role of inflammation and the unique features of different subsets of T cells and myeloid cells\, focusing on cancer and gut-specific immune responses; and how these cell subsets are involved in patient outcomes. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-roslyn-kemp
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/Roslyn-Kemp-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240827
DTEND;VALUE=DATE:20240828
DTSTAMP:20260413T072853
CREATED:20240822T042356Z
LAST-MODIFIED:20240827T173454Z
UID:5866-1724716800-1724803199@www.immunologypodcast.com
SUMMARY:Dr. Kipp Weiskopf
DESCRIPTION:Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. Dr. Weiskopf’s lab studies novel macrophage and myeloid immune checkpoints. Weiskopf began studying the CD47/SIRP⍺ interaction as a graduate student and demonstrated that CD47-blocking therapies could unleash immune attack against cancer and enhance a number of existing therapies. He also showed they could be used to treat small cell lung cancer and might permit bone marrow transplantation without using chemotherapy or radiation. The Weiskopf lab studies additional mechanisms that control myeloid cell activation in tumors to develop new treatments for cancer and other life-threatening diseases\, such as COVID-19.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kipp-weiskopf
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/kipp-weiskopf-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240813
DTEND;VALUE=DATE:20240814
DTSTAMP:20260413T072853
CREATED:20240731T163455Z
LAST-MODIFIED:20240815T173703Z
UID:5838-1723507200-1723593599@www.immunologypodcast.com
SUMMARY:Dr. Adrian Erlebacher
DESCRIPTION:Dr. Adrian Erlebacher is a Professor in the Department of Laboratory Medicine at the University of California San Francisco. His research lies at the intersection of immunology and developmental biology. In particular\, his lab is interested in how the developmental properties of a tissue influence its ability to mount a successful immune response\, and\, conversely\, how cells of the immune system influence tissue development and remodeling. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-adrian-erlebacher
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/07/Adrian-Erlebacher-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240730
DTEND;VALUE=DATE:20240731
DTSTAMP:20260413T072853
CREATED:20240605T203758Z
LAST-MODIFIED:20240731T163531Z
UID:5782-1722297600-1722383999@www.immunologypodcast.com
SUMMARY:Dr. Jeffrey Rathmell
DESCRIPTION:Dr. Jeffrey Rathmell is the Molecular Pathology and Immunology Associate Director\, Cornelius Vanderbilt Professor of Immunobiology\, and Director of the Vanderbilt Center for Immunobiology at Vanderbilt University Medical Center. Dr. Rathmell studies mechanisms by which extracellular cues influence lymphocyte death and differentiation in efforts to control inflammatory diseases and leukemia. Their work is highly interdisciplinary and collaborative involving the fields of immunology\, cancer biology\, and cell metabolism. They use genetic and biochemical approaches with a goal to understand and exploit the specific metabolic programs of each cell type or activation state and selectively modulate effector lymphocytes in inflammatory diseases and cancer. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jeffrey-rathmell
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/06/Jeffrey-Rathmell-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240702
DTEND;VALUE=DATE:20240703
DTSTAMP:20260413T072853
CREATED:20240403T184217Z
LAST-MODIFIED:20240702T224429Z
UID:5648-1719878400-1719964799@www.immunologypodcast.com
SUMMARY:Dr. Susan Kaech
DESCRIPTION:Dr. Susan Kaech is Professor and Director of the NOMIS Center for Immunobiology and Microbial Pathogenesis at the Salk Institute. She aims to understand how memory T cells are produced during infection and vaccination\, how they function and why they can fail to induce long-term immunity\, particularly during chronic disease or cancer. Her lab has been a leader in using genetic and molecular tools to identify the genes and signaling molecules involved in generating two specific types of memory T cells\, CD4 and CD8\, from precursor cells during both acute and chronic viral infections. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-susan-kaech
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/04/Susan-Kaech-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240612
DTSTAMP:20260413T072853
CREATED:20240605T202629Z
LAST-MODIFIED:20240605T202629Z
UID:5779-1718064000-1718150399@www.immunologypodcast.com
SUMMARY:Dr. Erika Moore
DESCRIPTION:Dr. Erika Moore is an Assistant Professor at the University of Maryland\, where she her lab is steadfastly committed to engineering biomaterial models that harness the regenerative potential of the immune system\, particularly addressing health disparities. Ongoing research at the Moore Lab encompasses a wide spectrum\, ranging from modeling vasculitis in lupus to investigating age-related macrophage function\, decoding extracellular matrix signaling’s impact on macrophage activity\, and examining ancestral influences on innate immune responses.\n \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-erika-moore
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/06/Erika-Moore-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240604
DTEND;VALUE=DATE:20240605
DTSTAMP:20260413T072853
CREATED:20240529T205211Z
LAST-MODIFIED:20240529T205211Z
UID:5766-1717459200-1717545599@www.immunologypodcast.com
SUMMARY:Dr. Kellen Cavagnero
DESCRIPTION:Dr. Kellen Cavagnero is a Postdoctoral Fellow at the University of California\, San Diego. Throughout his career\, Kellen’s research has focused on defining the events that occur after initial exposure to an inflammatory stimulus. His work aims to understand how fibroblasts—a cell type thought to be immunologically inert—contribute to chronic inflammatory conditions and defense against pathogens. His podcast\, Inflammatory Content\, aims to make science and the stories of the people behind the science accessible to everyone.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kellen-cavagnero
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/05/thumbnail_Kellen-Cavagnero-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240504T123000
DTEND;TZID=America/New_York:20240504T140000
DTSTAMP:20260413T072853
CREATED:20240327T160048Z
LAST-MODIFIED:20240617T211109Z
UID:5625-1714825800-1714831200@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: Artificial Intelligence and Immunology
DESCRIPTION:Join the Immunology Podcast for a live show at IMMUNOLOGY2024™! Brenda and Jason will chat with Drs. Jo Viney and Ryan Peckner from Seismic Therapeutic about how artificial intelligence is being used in immunology research. They will discuss how AI is contributing to innovations in the field\, including the use of machine learning in drug development. \nDate: May 4\, 2024\nTime: 12:30 – 2:00 p.m. EDT\nLocation: McCormick Place Convention Center\, Room W180 \nGuests:\nJo Viney\, PhD\nCEO\, President\, Co-Founder\, Seismic Therapeutic\nRyan Peckner\, PhD\nDirector of Machine Learning and Computational Biology\, Seismic Therapeutic\n\n\nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-artificial-intelligence-and-immunology
LOCATION:McCormick Place Convention Center\, 2301 S Martin Luther King Dr\, Chicago\, IL\, 60616\, United States
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Jo-and-Ryan-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240423
DTEND;VALUE=DATE:20240424
DTSTAMP:20260413T072853
CREATED:20240325T171649Z
LAST-MODIFIED:20240427T064005Z
UID:5629-1713830400-1713916799@www.immunologypodcast.com
SUMMARY:Dr. Caleb Lareau
DESCRIPTION:Dr. Caleb Lareau is an Assistant Professor at Memorial Sloan Kettering Cancer Center. His team of interdisciplinary scientists specializes in computational and translational immunology. Specifically\, they develop and utilize single-cell multi-omics technologies and computational biology to study human hematopoietic system as how immune cells change as we age and are exposed to pathogens\, including endemic viruses. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-caleb-lareau
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Caleb-Lareau-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240409
DTEND;VALUE=DATE:20240410
DTSTAMP:20260413T072853
CREATED:20240315T222703Z
LAST-MODIFIED:20240427T065232Z
UID:5618-1712620800-1712707199@www.immunologypodcast.com
SUMMARY:Dr. Mitchell Kronenberg
DESCRIPTION:Dr. Mitchell Kronenberg is a Professor and President Emeritus at La Jolla Institute for Immunology. He and his team study study innate-like T lymphocytes\, including natural killer T cells\,  mucosal-associated invariant T cells\, and gd T cells\, as well as innate lymphoid cells. They are also interested in mucosal immunology and the development of inflammatory bowel diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mitchell-kronenberg
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Mitch-Kronenberg.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240327
DTSTAMP:20260413T072853
CREATED:20240315T222114Z
LAST-MODIFIED:20240315T222141Z
UID:5614-1711411200-1711497599@www.immunologypodcast.com
SUMMARY:Dr. Scott Canna
DESCRIPTION:Dr. Scott Canna is an  Associate Professor of Pediatrics (Rheumatology) and Attending Physician\, Pediatric Rheumatology and Immune Dysregulation at the Children’s Hospital of Philadelphia. Dr. Canna’s group studies the intersections of hyper- and auto-inflammation. In particular\, they study two related disorders\, Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome\, because they typify the concept of hyperinflammation. They combine clinical insights from rheumatology and innate immunity with basic models of overwhelming systemic inflammation to define new disease subtypes and disease activity biomarkers\, to flesh out mechanisms of inflammatory disease\, and to test promising therapeutic strategies.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-scott-canna
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Scott-Canna-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240313
DTSTAMP:20260413T072853
CREATED:20240208T185231Z
LAST-MODIFIED:20240208T185231Z
UID:5563-1710201600-1710287999@www.immunologypodcast.com
SUMMARY:Dr. Neelika Malavige
DESCRIPTION:Dr. Neelika Malavige is a well-recognized leader in the field of dengue. She is the Head of Dengue Global Programme and Scientific Affairs at DNDi. She is also a Professor at the University of Sri Jayewardenepura. She previously was Head of the Department of Immunology and Molecular Medicine\, where her research focus on dengue was to find out the therapeutic targets\, notably mediators of vascular leak\, the role of antibodies in disease pathogenesis\, and correlates of protection in dengue.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-neelika-malavige
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/02/Neelika-420px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240227
DTEND;VALUE=DATE:20240228
DTSTAMP:20260413T072853
CREATED:20240131T181450Z
LAST-MODIFIED:20240228T024043Z
UID:5548-1708992000-1709078399@www.immunologypodcast.com
SUMMARY:Dr. James Allison
DESCRIPTION:Dr. James Allison is Regental Professor and Chair of the Department of Immunology\, the Olga Keith Wiess Distinguished University Chair for Cancer Research\, Director of the Parker Institute for Cancer Research\, Executive Director of the Immunotherapy Platform\, and Director of the James P. Allison Institute at MD Anderson Cancer Center. He has spent a distinguished career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine\, which he shared with Dr. Tasuku Honjo\, “for their discovery of cancer therapy by inhibition of negative immune regulation.” \nAmong his most notable discoveries are the determination of the T cell receptor structure and that CD28 is the major costimulatory molecule that allows full activation of naïve T cells and prevents anergy in T cell clones. His lab resolved a major controversy by demonstrating that CTLA-4 inhibits T-cell activation by opposing CD28-mediated costimulation and that blockade of CTLA-4 could enhance T cell responses\, leading to tumor rejection in animal models. This finding and a great deal of persistence paved the way for the field of immune checkpoint blockade therapy for cancer. \nWork in his lab led to the development of ipilimumab\, an antibody to human CTLA-4 and the first immune checkpoint blockade therapy approved by the FDA. Among many honors\, he is a member of the National Academies of Science and Medicine and received the Lasker-Debakey Clinical Medical Research award in 2015. His current work seeks to improve immune checkpoint blockade therapies currently used by our clinicians and identify new targets to unleash the immune system in order to eradicate cancer. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-james-allison
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/01/James-Allison-420-px.jpg
END:VEVENT
END:VCALENDAR